THY1 Antibody, FITC conjugated

說明書

中文名稱：

THY1兔多克隆抗體, FITC偶聯
貨號：

CSB-PA023525LC01HU
規格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) THY1 Polyclonal antibody
Uniprot No.：

P04216
基因名：

THY1
別名：

CD7 antibody; CD90 antibody; CD90 antigen antibody; CDw90 antibody; FLJ33325 antibody; MGC128895 antibody; T25 antibody; Theta antigen antibody; Thy 1 antibody; Thy 1 cell surface antigen antibody; Thy 1 membrane glycoprotein antibody; Thy 1 T cell antigen antibody; Thy 1.2 antibody; Thy-1 antigen antibody; Thy-1 membrane glycoprotein antibody; Thy1 antibody; Thy1 antigen antibody; Thy1 T cell antigen antibody; Thy1.1 antibody; Thy1.2 antibody; THY1_HUMAN antibody; Thymus cell antigen 1, theta antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Thy-1 membrane glycoprotein protein (20-130AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

FITC
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產品提供形式：

Liquid
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

May play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.
基因功能參考文獻：
1. High CD90 expression is associated with lymph node metastasis in intrahepatic cholangiocarcinoma. PMID: 30196535
2. Data indicate that CD90 is an actor of glioblastoma (GBM) invasiveness through SRC-dependent mechanisms. PMID: 28939749
3. Results show that CD90 distinguishes two interrelated, yet functionally distinct pericyte populations in the adult human brain that may have discrete roles in neurovascular function, immune response and scar formation. PMID: 27215737
4. number of Thy-1(+) human peritoneal fibroblasts increased significantly in peritoneal dialysis patients PMID: 28724609
5. CD90, CD166, and GD2 were identified as potential cancer stem cell markers. PMID: 27049037
6. hese results suggest that LNGFR(+)THY-1(+) cells identified following NCLC induction from ESCs/iPSCs shared similar potentials with multipotent MSCs. PMID: 27178356
7. High THY1 expression is associated with lung cancer. PMID: 27513329
8. co-expression of CD90 and CD24 may have an important role in the development and progression of pancreatic intraepithelial neoplasia. PMID: 27332878
9. Low CD90 expression is associated with ovarian cancer. PMID: 27633757
10. Positive Thy1 and CD49f expression is significantly associated with the progression and poor prognosis of chondrosarcoma. PMID: 27155928
11. CD90 could be used as a potential biomarker for Hepatocellular Carcinoma liver cancer stem cells, and cancer stem cell activity was elevated through up activated Notch pathway in CD90+ liver cancer stem cells. PMID: 26848615
12. CD90 controls the differentiation of mesenchymal stromal cells by acting as an obstacle in the pathway of differentiation commitment. PMID: 27465541
13. CD105+/CD90+ subpopulation from breast cancer MDA-MB-231 cells possesses "mesenchymal stem cell-like" characteristics, and its high migratory ability might be associated with epithelial-mesenchymal transformation. PMID: 26191205
14. we found that THY-1 mediates human cytomegalovirus infection at the entry step and is important for infection PMID: 26147640
15. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. PMID: 26272696
16. CD90 could serve as a promising marker for pancreatic adenocarcinoma. PMID: 25536077
17. Dynamic catch of a Thy-1-integrin alpha5beta1+syndecan-4 trimolecular complex explains extraordinary cancer cell adhesion to the vascular endothelium. PMID: 25216363
18. these data suggest that CD90+CXCR4+ HCC cells may be CTSCs and selective elimination of these cells may substantially improve the current hepatocellular carcinoma therapy by reducing cancer metastasis. PMID: 25672610
19. CD133, CD44, and CD90 could be used as prognostic and predictive markers in hepatoblastoma. PMID: 25168019
20. Wnt/beta-catenin aids in regulating the proliferation of hepG2 cells mediated by thy-1. PMID: 25061736
21. THY1 may be a promising novel prognostic marker for male breast cancer. PMID: 24194916
22. We found that the vast majority of CD90(+) dermal cells are perivascularly located and generate a significantly higher percentage of regulatory T cells compared with cells expressing markers such as CD271 in vitro. PMID: 25050599
23. TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells. PMID: 25070848
24. In the present study we analyzed the expression of four cell surface antigens relevant to human hematopoiesis-CD90, CD96, CD117, and CD123-in bone marrow from pediatric acute myeloid leukemia patients and normal control subjects. PMID: 24751333
25. Results indicate the importance of CD90 in the hepatocellular carcinoma (HCC). PMID: 24116172
26. These findings suggest that CD90 could be a potential marker of lung cancer stem cells and thus provide new insight into further therapeutic strategies of lung cancer. PMID: 24101104
27. CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry. PMID: 24045552
28. These results indicate that suppression of the RhoA-mediated pathway might participate in the Thy-1-induced migration inhibition in human umbilical vein endothelial cells. PMID: 23613866
29. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. PMID: 23438193
30. High CD90 tumor-initiating cell population is associated with an aggressive signature and metastatic capacity in esophageal cancer. PMID: 23382045
31. We demonstrated that the expression of CSC marker CD90 is related to the expression of BORIS in hepatocellular carcinoma (HCC) tissue and HCC cell lines. PMID: 23237599
32. Thy-1 contributes to metastasis of melanoma cells by mechanisms involving a Thy-1-mediated adhesion of melanoma cells to endothelial cells. PMID: 23159525
33. concentrations were increased in the sera of systemic sclerosis patients, particularly in those with vascular involvement of the lungs PMID: 22807289
34. an increased chondrogenic potential within the CD90+ fraction of human and canine synovial fluid mesenchymal progenitor cells PMID: 22952721
35. The researchers demonstrate the role of CD90 as a marker of cancer stem cells within high-grade gliomas PMID: 22426060
36. CD90 is not only a potential prognostic marker for high-grade gliomas but also a marker for cancer stem cells within gliomas PMID: 22203689
37. human CD90 identifies a subset of Th17 and Tc17 cells within CD4(+) and CD8(+) T cells, respectively, which are depleted during HIV infection PMID: 22184726
38. binding of leukocytes to activated endothelium mediated by the interaction of CD97 with Thy-1 is involved in firm adhesion of polymorphonuclear cells during inflammation and may play a role in the regulation of leukocyte trafficking to inflammatory sites. PMID: 22210915
39. Data show that a cell population with the CD90 phenotype is enriched in sphere-cultured cells from gastric primary tumors. PMID: 21743497
40. overexpression of Thy1 may not suppress the development of hepatocellular carcinoma(HCC) Thy1 could provide a clinical prognostic marker for HC PMID: 21272924
41. Loss of Thy-1 in human lung fibroblasts induces a fibrogenic phenotype. PMID: 21577212
42. we have identified a stromal cell type (CD90+ fibroblasts) and a molecule (CD90) that distinguishes cancer-associated stroma from 'benign' stroma in the prostate PMID: 20562849
43. The decreased level of THY1 expression may be related with the occurrence and development of ovarian serous cystadenocarcinoma. PMID: 19538887
44. Down-regulated/loss expression of THY1 protein in epithelial ovarian cancer is significantly correlated with cancer cell proliferation and metastasis in the epithelial ovarian cancer. PMID: 19615261
45. Thy-1-integrin alpha(v)beta(5) interactions inhibit contraction-induced latent TGF-beta1 activation, presumably by blocking the binding of extracellular matrix-bound latent TGF-beta1 with integrin alpha(v)beta(5). PMID: 20463011
46. Loss of expression of THY1 is associated with nasopharyngeal carcinoma. PMID: 19921696
47. the distribution and proportion of CD90 positive cells in thyroid associated ophthalmopathy (TAO) and normal orbital tissue PMID: 17243294
48. down-regulated KLF4, CHGA,GPX3, SST and LIPF, together with up-regulated SERPINH1, THY1 and INHBA is an 8-gene signature for gastric cancer PMID: 20043075
49. Review article on CD90 structure and function. PMID: 11860231
50. Thy-1/Thy-1 ligand interaction may play a role in adhesion of melanoma cells to endothelial cells PMID: 12074634
顯示更多

收起更多
亞細胞定位：

Cell membrane; Lipid-anchor, GPI-anchor.
數據庫鏈接：

HGNC: 11801

OMIM: 188230

KEGG: hsa:7070

STRING: 9606.ENSP00000284240

UniGene: Hs.644697

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human